Wang Yu-Hong, Ouyang Qing, Zhao Shuang, Zhang Yue, Tian Run-Ze, Guo Yan-Ping, Zheng Rui, Nasser Moussa Ide, Li Ge, Zhu Ping
Department of Cardiac Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangdong Cardiovascular Institute, 510100 Guangzhou, Guangdong, China.
Guangdong Provincial Key Laboratory of Pathogenesis, Targeted Prevention and Treatment of Heart Disease, Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 510080 Guangzhou, Guangdong, China.
Front Biosci (Landmark Ed). 2023 Sep 25;28(9):221. doi: 10.31083/j.fbl2809221.
Cardiovascular diseases rank as the leading cause of death worldwide and are a major contributor to disability, posing a significant threat to human health. Organoids offer a partial simulation of the structure and function of the tissue of origin. It is a promising model that can supplement the disadvantages of two-dimensional culture and animal models. Due to the complexity of heart development, the research of cardiac organoids is still maturing. The advancement of technology has helped address certain challenges, but it has also unveiled new issues and complexities. This paper summarizes the application of organoids technology in the cardiovascular field, the common construction methods of cardiac organoids, and the latest progress of cardiac organoids in the fields of disease model construction, cardiac development research, drug research, and regenerative medicine. The future development and challenges of cardiac organoids are also addressed.
心血管疾病是全球主要的死亡原因,也是导致残疾的主要因素,对人类健康构成重大威胁。类器官能够部分模拟其起源组织的结构和功能。它是一种很有前景的模型,可以弥补二维培养和动物模型的不足。由于心脏发育的复杂性,心脏类器官的研究仍在不断成熟。技术的进步有助于解决某些挑战,但也带来了新的问题和复杂性。本文综述了类器官技术在心血管领域的应用、心脏类器官的常见构建方法,以及心脏类器官在疾病模型构建、心脏发育研究、药物研究和再生医学等领域的最新进展。同时也探讨了心脏类器官未来的发展和面临的挑战。